Search

everythinglearnresearchcommunity

for

Search:↓

Valproate sustained-release is effective and generally safe for short-term treatment of new partial epilepsy.

The treatment is safe and shows promise for metastatic breast cancer.

Sacituzumab tirumotecan shows promise in treating breast cancer with manageable side effects.

The man's symptoms improved after treating his scurvy with high-dose vitamin C.

HIV medication ritonavir can increase the effects of nasal sprays like fluticasone, causing Cushing's syndrome.

Indinavir can cause hair loss and other skin problems.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Cepharanthine and tetrandrine show promise as COVID-19 drugs.

Blocking enzymes that help the virus enter cells could be a promising way to treat COVID-19.

Isotretinoin effectively treated severe acne in HIV-positive women, with improved skin and CD4 counts, but some experienced side effects like skin dryness and hair loss.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

Fipronil effectively treats Lynxacarus radovskyi in outdoor cats.

Rimegepant causes more nausea and skin issues, while ubrogepant causes more muscle issues; personalized treatment is important.

Hydroxychloroquine, nitazoxanide, and ivermectin were similarly effective in treating early COVID-19.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

9-cis-retinoic acid showed some effectiveness in treating AIDS-related Kaposi sarcoma but had significant side effects at higher doses.

New treatments for Hepatitis C show promise but need more research to confirm their safety and effectiveness for clinical use.

Some synthetic carbohydrate receptors, especially compounds 3 and 15, show strong potential for treating Zika virus.

Four drugs were found that could potentially treat COVID-19 by inhibiting the virus in lab tests.

Oral valganciclovir improved a patient's skin condition caused by immunosuppression.

A woman with HIV had a severe skin condition that improved with antiretroviral therapy.

Interferon and ribavirin can cause serious skin reactions and other health issues.

Avacopan is generally safe, with some minor side effects like nausea and fatigue.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Cepharanthine effectively reduces Herpes Simplex Virus Type 1 by blocking certain cell pathways and promoting cell death.

The described COVID-19 treatments seemed effective in influencing the disease's course, duration, and severity.

Vismodegib effectively treats advanced basal cell carcinoma but requires careful management of serious side effects.